APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dupilumab Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dupilumab Injection Market Analysis and Forecast 2026-2032

29 December 2025195 pages

Choose your research edition.

Industry ResearchDupilumab Injection Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Dupilumab Injection Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Dupilumab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dupilumab Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Dupilumab Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Dupilumab Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dupilumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dupilumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dupilumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dupilumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dupilumab Injection include Regeneron and Sanofi etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dupilumab Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dupilumab Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Dupilumab Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dupilumab Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dupilumab Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dupilumab Injection sales, projected growth trends, production technology, application and end-user industry.

Dupilumab Injection Segment by Company

Regeneron

Sanofi

Dupilumab Injection Segment by Type

200mg (1.14mL)/Vial

300mg (2.0 mL)/Vial

Dupilumab Injection Segment by Application

Asthma

Atopic Dermatitis

Chronic Sinusitis with Nasal Polyps

Other

Dupilumab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dupilumab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dupilumab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dupilumab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dupilumab Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dupilumab Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dupilumab Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dupilumab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 200mg (1.14mL)/Vial Major Manufacturers Table 3. 300mg (2.0 mL)/Vial Major Manufacturers Table 4. Global Dupilumab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Asthma Major Manufacturers Table 6. Atopic Dermatitis Major Manufacturers Table 7. Chronic Sinusitis with Nasal Polyps Major Manufacturers Table 8. Other Major Manufacturers Table 9. Dupilumab Injection Industry Trends Table 10. Dupilumab Injection Industry Drivers Table 11. Dupilumab Injection Industry Opportunities and Challenges Table 12. Dupilumab Injection Industry Restraints Table 13. Global Dupilumab Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Dupilumab Injection Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Dupilumab Injection Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Dupilumab Injection Revenue Market Share by Region (2021-2026) Table 17. Global Dupilumab Injection Revenue Market Share by Region (2027-2032) Table 18. Global Dupilumab Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Dupilumab Injection Sales by Region (2021-2026) & (K Units) Table 20. Global Dupilumab Injection Sales by Region (2027-2032) & (K Units) Table 21. Global Dupilumab Injection Sales Market Share by Region (2021-2026) Table 22. Global Dupilumab Injection Sales Market Share by Region (2027-2032) Table 23. Global Dupilumab Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Dupilumab Injection Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Dupilumab Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Dupilumab Injection Sales Market Share by Manufacturers (2021-2026) Table 27. Global Dupilumab Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Dupilumab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Dupilumab Injection Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Dupilumab Injection Manufacturers, Product Type & Application Table 31. Global Dupilumab Injection Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Dupilumab Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Dupilumab Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Dupilumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Dupilumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Dupilumab Injection Revenue Market Share by Type (2021-2026) Table 38. Global Dupilumab Injection Revenue Market Share by Type (2027-2032) Table 39. Global Dupilumab Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Dupilumab Injection Sales by Type (2021-2026) & (K Units) Table 41. Global Dupilumab Injection Sales by Type (2027-2032) & (K Units) Table 42. Global Dupilumab Injection Sales Market Share by Type (2021-2026) Table 43. Global Dupilumab Injection Sales Market Share by Type (2027-2032) Table 44. Global Dupilumab Injection Price by Type (2021-2026) & (US$/Unit) Table 45. Global Dupilumab Injection Price by Type (2027-2032) & (US$/Unit) Table 46. Global Dupilumab Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Dupilumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Dupilumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Dupilumab Injection Revenue Market Share by Application (2021-2026) Table 50. Global Dupilumab Injection Revenue Market Share by Application (2027-2032) Table 51. Global Dupilumab Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Dupilumab Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Dupilumab Injection Sales by Application (2027-2032) & (K Units) Table 54. Global Dupilumab Injection Sales Market Share by Application (2021-2026) Table 55. Global Dupilumab Injection Sales Market Share by Application (2027-2032) Table 56. Global Dupilumab Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Dupilumab Injection Price by Application (2027-2032) & (US$/Unit) Table 58. Regeneron Company Information Table 59. Regeneron Business Overview Table 60. Regeneron Dupilumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Regeneron Dupilumab Injection Product Portfolio Table 62. Regeneron Recent Development Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Dupilumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sanofi Dupilumab Injection Product Portfolio Table 67. Sanofi Recent Development Table 68. North America Dupilumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Dupilumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Dupilumab Injection Sales by Type (2021-2026) & (K Units) Table 71. North America Dupilumab Injection Sales by Type (2027-2032) & (K Units) Table 72. North America Dupilumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 73. North America Dupilumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 74. North America Dupilumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Dupilumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Dupilumab Injection Sales by Application (2021-2026) & (K Units) Table 77. North America Dupilumab Injection Sales by Application (2027-2032) & (K Units) Table 78. North America Dupilumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 79. North America Dupilumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 80. North America Dupilumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Dupilumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America Dupilumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America Dupilumab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 84. North America Dupilumab Injection Sales by Country (2021-2026) & (K Units) Table 85. North America Dupilumab Injection Sales by Country (2027-2032) & (K Units) Table 86. North America Dupilumab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 87. North America Dupilumab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 88. United States Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 89. Canada Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 90. Mexico Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 91. Europe Dupilumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Dupilumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Dupilumab Injection Sales by Type (2021-2026) & (K Units) Table 94. Europe Dupilumab Injection Sales by Type (2027-2032) & (K Units) Table 95. Europe Dupilumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 96. Europe Dupilumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 97. Europe Dupilumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Dupilumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Dupilumab Injection Sales by Application (2021-2026) & (K Units) Table 100. Europe Dupilumab Injection Sales by Application (2027-2032) & (K Units) Table 101. Europe Dupilumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 102. Europe Dupilumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 103. Europe Dupilumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Dupilumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. Europe Dupilumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. Europe Dupilumab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 107. Europe Dupilumab Injection Sales by Country (2021-2026) & (K Units) Table 108. Europe Dupilumab Injection Sales by Country (2027-2032) & (K Units) Table 109. Europe Dupilumab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 110. Europe Dupilumab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 111. Germany Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 112. France Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 113. U.K. Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 114. Italy Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 115. Russia Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 116. Spain Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 117. Netherlands Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 118. Switzerland Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 119. Sweden Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 120. Poland Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 121. China Dupilumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 122. China Dupilumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 123. China Dupilumab Injection Sales by Type (2021-2026) & (K Units) Table 124. China Dupilumab Injection Sales by Type (2027-2032) & (K Units) Table 125. China Dupilumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 126. China Dupilumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 127. China Dupilumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 128. China Dupilumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 129. China Dupilumab Injection Sales by Application (2021-2026) & (K Units) Table 130. China Dupilumab Injection Sales by Application (2027-2032) & (K Units) Table 131. China Dupilumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 132. China Dupilumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Asia Dupilumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Dupilumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Dupilumab Injection Sales by Type (2021-2026) & (K Units) Table 136. Asia Dupilumab Injection Sales by Type (2027-2032) & (K Units) Table 137. Asia Dupilumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 138. Asia Dupilumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 139. Asia Dupilumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Dupilumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Dupilumab Injection Sales by Application (2021-2026) & (K Units) Table 142. Asia Dupilumab Injection Sales by Application (2027-2032) & (K Units) Table 143. Asia Dupilumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 144. Asia Dupilumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 145. Asia Dupilumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Dupilumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Asia Dupilumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Asia Dupilumab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 149. Asia Dupilumab Injection Sales by Country (2021-2026) & (K Units) Table 150. Asia Dupilumab Injection Sales by Country (2027-2032) & (K Units) Table 151. Asia Dupilumab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 152. Asia Dupilumab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 153. Japan Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 154. South Korea Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 155. India Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 156. Australia Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 157. Taiwan Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 158. Southeast Asia Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 159. SAMEA Dupilumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Dupilumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Dupilumab Injection Sales by Type (2021-2026) & (K Units) Table 162. SAMEA Dupilumab Injection Sales by Type (2027-2032) & (K Units) Table 163. SAMEA Dupilumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 164. SAMEA Dupilumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 165. SAMEA Dupilumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Dupilumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Dupilumab Injection Sales by Application (2021-2026) & (K Units) Table 168. SAMEA Dupilumab Injection Sales by Application (2027-2032) & (K Units) Table 169. SAMEA Dupilumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 170. SAMEA Dupilumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 171. SAMEA Dupilumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Dupilumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. SAMEA Dupilumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. SAMEA Dupilumab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. SAMEA Dupilumab Injection Sales by Country (2021-2026) & (K Units) Table 176. SAMEA Dupilumab Injection Sales by Country (2027-2032) & (K Units) Table 177. SAMEA Dupilumab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 178. SAMEA Dupilumab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Brazil Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 180. Argentina Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 181. Chile Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 182. Colombia Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 183. Peru Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 184. Saudi Arabia Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 185. Israel Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 186. UAE Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 187. Turkey Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 188. Iran Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 189. Egypt Dupilumab Injection Revenue (2021-2032) & (US$ Million) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Dupilumab Injection Distributors List Table 193. Dupilumab Injection Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Dupilumab Injection Image Figure 2. Global Dupilumab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dupilumab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 200mg (1.14mL)/Vial Image Figure 5. 300mg (2.0 mL)/Vial Image Figure 6. Global Dupilumab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dupilumab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Asthma Image Figure 9. Atopic Dermatitis Image Figure 10. Chronic Sinusitis with Nasal Polyps Image Figure 11. Other Image Figure 12. Global Dupilumab Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Dupilumab Injection Revenue (2021-2032) & (US$ Million) Figure 14. Global Dupilumab Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Dupilumab Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Dupilumab Injection Revenue Market Share by Region (2021-2032) Figure 17. Global Dupilumab Injection Sales (2021-2032) & (K Units) Figure 18. Global Dupilumab Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Dupilumab Injection Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Dupilumab Injection Sales YoY (2021-2032) & (K Units) Figure 21. Europe Dupilumab Injection Sales YoY (2021-2032) & (K Units) Figure 22. China Dupilumab Injection Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Dupilumab Injection Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Dupilumab Injection Sales YoY (2021-2032) & (K Units) Figure 25. Global Dupilumab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Dupilumab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Dupilumab Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Dupilumab Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Dupilumab Injection Revenue Market Share by Type (2021-2032) Figure 31. Global Dupilumab Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Dupilumab Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Dupilumab Injection Sales Market Share by Type (2021-2032) Figure 34. Global Dupilumab Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Dupilumab Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Dupilumab Injection Revenue Market Share by Application (2021-2032) Figure 37. Global Dupilumab Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Dupilumab Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Dupilumab Injection Sales Market Share by Application (2021-2032) Figure 40. North America Dupilumab Injection Revenue Share by Type (2021-2032) Figure 41. North America Dupilumab Injection Sales Share by Type (2021-2032) Figure 42. North America Dupilumab Injection Revenue Share by Application (2021-2032) Figure 43. North America Dupilumab Injection Sales Share by Application (2021-2032) Figure 44. North America Dupilumab Injection Revenue Share by Country (2021-2032) Figure 45. North America Dupilumab Injection Sales Share by Country (2021-2032) Figure 46. Europe Dupilumab Injection Revenue Share by Type (2021-2032) Figure 47. Europe Dupilumab Injection Sales Share by Type (2021-2032) Figure 48. Europe Dupilumab Injection Revenue Share by Application (2021-2032) Figure 49. Europe Dupilumab Injection Sales Share by Application (2021-2032) Figure 50. Europe Dupilumab Injection Revenue Share by Country (2021-2032) Figure 51. Europe Dupilumab Injection Sales Share by Country (2021-2032) Figure 52. China Dupilumab Injection Revenue Share by Type (2021-2032) Figure 53. China Dupilumab Injection Sales Share by Type (2021-2032) Figure 54. China Dupilumab Injection Revenue Share by Application (2021-2032) Figure 55. China Dupilumab Injection Sales Share by Application (2021-2032) Figure 56. Asia Dupilumab Injection Revenue Share by Type (2021-2032) Figure 57. Asia Dupilumab Injection Sales Share by Type (2021-2032) Figure 58. Asia Dupilumab Injection Revenue Share by Application (2021-2032) Figure 59. Asia Dupilumab Injection Sales Share by Application (2021-2032) Figure 60. Asia Dupilumab Injection Revenue Share by Country (2021-2032) Figure 61. Asia Dupilumab Injection Sales Share by Country (2021-2032) Figure 62. SAMEA Dupilumab Injection Revenue Share by Type (2021-2032) Figure 63. SAMEA Dupilumab Injection Sales Share by Type (2021-2032) Figure 64. SAMEA Dupilumab Injection Revenue Share by Application (2021-2032) Figure 65. SAMEA Dupilumab Injection Sales Share by Application (2021-2032) Figure 66. SAMEA Dupilumab Injection Revenue Share by Country (2021-2032) Figure 67. SAMEA Dupilumab Injection Sales Share by Country (2021-2032) Figure 68. Dupilumab Injection Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Dupilumab Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 200mg (1.14mL)/Vial
  • 300mg (2.0 mL)/Vial
Applications
  • Asthma
  • Atopic Dermatitis
  • Chronic Sinusitis with Nasal Polyps
  • Other
Companies covered
  • Regeneron
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dupilumab Injection Market by Type
  3. 1.2.1 Global Dupilumab Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 200mg (1.14mL)/Vial
  5. 1.2.3 300mg (2.0 mL)/Vial
  6. 1.3 Dupilumab Injection Market by Application
  7. 1.3.1 Global Dupilumab Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Asthma
  9. 1.3.3 Atopic Dermatitis
  10. 1.3.4 Chronic Sinusitis with Nasal Polyps
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Dupilumab Injection Market Dynamics
  1. 2.1 Dupilumab Injection Industry Trends
  2. 2.2 Dupilumab Injection Industry Drivers
  3. 2.3 Dupilumab Injection Industry Opportunities and Challenges
  4. 2.4 Dupilumab Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dupilumab Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dupilumab Injection Revenue by Region
  3. 3.2.1 Global Dupilumab Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dupilumab Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Dupilumab Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Dupilumab Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dupilumab Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dupilumab Injection Sales by Region
  9. 3.4.1 Global Dupilumab Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dupilumab Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Dupilumab Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Dupilumab Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dupilumab Injection Revenue by Manufacturers
  2. 4.1.1 Global Dupilumab Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dupilumab Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dupilumab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dupilumab Injection Sales by Manufacturers
  6. 4.2.1 Global Dupilumab Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dupilumab Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dupilumab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dupilumab Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dupilumab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dupilumab Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dupilumab Injection Manufacturers, Product Type & Application
  13. 4.7 Global Dupilumab Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dupilumab Injection Market CR5 and HHI
  16. 4.8.2 2025 Dupilumab Injection Tier 1, Tier 2, and Tier 3
5 Dupilumab Injection Market by Type
  1. 5.1 Global Dupilumab Injection Revenue by Type
  2. 5.1.1 Global Dupilumab Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dupilumab Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dupilumab Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dupilumab Injection Sales by Type
  6. 5.2.1 Global Dupilumab Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dupilumab Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Dupilumab Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dupilumab Injection Price by Type
6 Dupilumab Injection Market by Application
  1. 6.1 Global Dupilumab Injection Revenue by Application
  2. 6.1.1 Global Dupilumab Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dupilumab Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dupilumab Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dupilumab Injection Sales by Application
  6. 6.2.1 Global Dupilumab Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dupilumab Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Dupilumab Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dupilumab Injection Price by Application
7 Company Profiles
  1. 7.1 Regeneron
  2. 7.1.1 Regeneron Company Information
  3. 7.1.2 Regeneron Business Overview
  4. 7.1.3 Regeneron Dupilumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Regeneron Dupilumab Injection Product Portfolio
  6. 7.1.5 Regeneron Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Dupilumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Dupilumab Injection Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
8 North America
  1. 8.1 North America Dupilumab Injection Market Size by Type
  2. 8.1.1 North America Dupilumab Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Dupilumab Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Dupilumab Injection Price by Type (2021-2032)
  5. 8.2 North America Dupilumab Injection Market Size by Application
  6. 8.2.1 North America Dupilumab Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Dupilumab Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Dupilumab Injection Price by Application (2021-2032)
  9. 8.3 North America Dupilumab Injection Market Size by Country
  10. 8.3.1 North America Dupilumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dupilumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dupilumab Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dupilumab Injection Market Size by Type
  2. 9.1.1 Europe Dupilumab Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dupilumab Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Dupilumab Injection Price by Type (2021-2032)
  5. 9.2 Europe Dupilumab Injection Market Size by Application
  6. 9.2.1 Europe Dupilumab Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dupilumab Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Dupilumab Injection Price by Application (2021-2032)
  9. 9.3 Europe Dupilumab Injection Market Size by Country
  10. 9.3.1 Europe Dupilumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dupilumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dupilumab Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dupilumab Injection Market Size by Type
  2. 10.1.1 China Dupilumab Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Dupilumab Injection Sales by Type (2021-2032)
  4. 10.1.3 China Dupilumab Injection Price by Type (2021-2032)
  5. 10.2 China Dupilumab Injection Market Size by Application
  6. 10.2.1 China Dupilumab Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Dupilumab Injection Sales by Application (2021-2032)
  8. 10.2.3 China Dupilumab Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dupilumab Injection Market Size by Type
  2. 11.1.1 Asia Dupilumab Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dupilumab Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Dupilumab Injection Price by Type (2021-2032)
  5. 11.2 Asia Dupilumab Injection Market Size by Application
  6. 11.2.1 Asia Dupilumab Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dupilumab Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Dupilumab Injection Price by Application (2021-2032)
  9. 11.3 Asia Dupilumab Injection Market Size by Country
  10. 11.3.1 Asia Dupilumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dupilumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dupilumab Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dupilumab Injection Market Size by Type
  2. 12.1.1 SAMEA Dupilumab Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dupilumab Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dupilumab Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Dupilumab Injection Market Size by Application
  6. 12.2.1 SAMEA Dupilumab Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dupilumab Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dupilumab Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Dupilumab Injection Market Size by Country
  10. 12.3.1 SAMEA Dupilumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dupilumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dupilumab Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dupilumab Injection Value Chain Analysis
  2. 13.1.1 Dupilumab Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dupilumab Injection Production Mode & Process
  6. 13.2 Dupilumab Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dupilumab Injection Distributors
  9. 13.2.3 Dupilumab Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst